Antibody persistence up to 5y after vaccination with a quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine in adolescents

Quiambao, BP; Bavdekar, A; Dubey, AP; Jain, H; Kolhe, D; Bianco, V; Miller, JM; Van der Wielen, M

Van der Wielen, M (reprint author), GSK Vaccines, Ave Fleming, B-1300 Wavre, Belgium.

HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2017; 13 (3): 636

Abstract

Long-term protection against meningococcal disease relies on antibody persistence after vaccination. We report antibody persistence up to 5y after vac......

Full Text Link